A patient’s symptom severity is the first and most important check when determining whether clinic-based or at-home ketamine therapy is the right fit.
Those with acute suicidality, unstable psychiatric symptoms, or complex comorbidities often benefit from the structured monitoring of a ketamine clinic, where medical staff can intervene if dissociation or blood pressure fluctuations occur.
Stable patients with moderate treatment-resistant depression, a solid support system, and no active safety risks may benefit from at-home compounded ketamine, avoiding the burden of frequent clinic visits.
IV ketamine infusions and commercial products like Spravato require clinical visits and supervision for every administration of the drug.
Clinical visits have positive features, but logistically, they may not work for every patient.
Travel distance and time commitments can make regular visits impractical, especially for those in rural areas or with mobility challenges.
Patients with demanding work schedules, long travel distances, or just little free time may struggle to adhere to the in-person therapy sessions vs in-home applications.
Patients cannot drive themselves to their ketamine infusion appointments since they experience impaired judgment and slower reaction times post-administration.
Additionally, patients are recommended to be driven by a trusted and known person. Ride-sharing services and public transportation are often ruled out due to exposure to strangers and an environment of uncertainty during a sensitive period post-ketamine administration.
The patient’s insurance coverage can influence the cost and affordability of each therapy option.
In addition to the actual cost of the medication, it is worthwhile to consider the money spent driving to and from the clinic, including time taken off from work, etc.
Many patients find that insurance companies are covering or partially covering costs for their ketamine therapy. This includes the FDA-approved nasal spray Spravato and even IV infusions from reputable ketamine clinics.
Patients can experience a significant reduction in out-of-pocket costs in this manner.
Compounded ketamine nasal sprays are the only option that allows the patient to administer the medication at home. The vast majority of the time, this option is not covered by insurance.
However, the affordability of compounded nasal sprays can still make the price comparable or better when compared to options covered by insurance. It is essential to compare the costs when making this decision.
Choosing between in-home and in-clinic ketamine therapy is about finding the right option for your patient’s unique needs. Symptom severity, lifestyle logistics, and affordability all play pivotal roles in determining whether clinic supervision or at-home flexibility will lead to better adherence and outcomes.
For high-risk patients, the structure of a clinic may be non-negotiable. For others, compounded ketamine could be the key to consistent, accessible relief.
By weighing these factors carefully, you can empower your patients to pursue ketamine therapy with confidence and finally achieve the breakthrough they’ve been waiting for.
Call/Text: (303) 333-2010
Fax: (303) 333-2208
Monday – Friday: 10 am to 6 pm
Saturday: 10 am to 2 pm
Sunday: Closed
Monday – Friday: 9 am to 6 pm
Saturday: 9 am to 1 pm
Sunday: Closed
Call/Text: (303) 795-4300
Fax: (303) 795-5849
Monday – Friday: 8 am to 5 pm
Saturday & Sunday: Closed
DISCLAIMER: A prescription from a licensed practitioner is required for compounded medications.
The content and photographs on this website are copyrighted or licensed material and may not be downloaded for other than personal use. Retransmission, republication, reproduction, or any other use of the content or photographs is prohibited.
©ClearSpring Pharmacy
Website Development by Storey Marketing
